AstraZeneca plc
Bristol-myers Squibb Company
Chipscreen Biosciences Ltd. Eisai Co. Ltd. Eli Lilly and Company
F. Hoffmann-La Roche AG
GlaxoSmithKline plc
Merck & Co. Inc. Novartis AG
Pfizer Inc. Radius Health Inc. Syndax Pharmaceuticals Inc.
Published | Pages | Publisher | Report code |
---|---|---|---|
Mar 2023 | 72 | GEN Consulting | ASDR-616763 |
AstraZeneca plc
Bristol-myers Squibb Company
Chipscreen Biosciences Ltd. Eisai Co. Ltd. Eli Lilly and Company
F. Hoffmann-La Roche AG
GlaxoSmithKline plc
Merck & Co. Inc. Novartis AG
Pfizer Inc. Radius Health Inc. Syndax Pharmaceuticals Inc.